Kyowa Kirin funds independent research and education in rare diseases and hematologic cancers, with a current focus on CTCL and related scientific and community health initiatives.
Funder: Kyowa Kirin
Due Dates: July 31, 2026 (Applications due — CTCL CME Grant)
Funding Amounts: $5,000–$100,000 per project (CTCL CME Grant); other grants may vary
Summary: Supports independent research, education, and patient-focused programs in rare diseases, hematologic cancers, and community health, with a current RFP for CTCL CME initiatives.
Key Information: Proposals must be submitted at least 90 days before program start; individual HCPs or physician practices are not eligible.
Kyowa Kirin provides grants to support independent research, education, and patient advocacy initiatives aligned with its mission to improve outcomes for patients, families, and healthcare professionals. The current focus includes rare hematologic cancers (notably Cutaneous T-Cell Lymphoma, or CTCL), bone and mineral diseases, and efforts to address healthcare disparities and social determinants of health. Funding is available for independent medical education, fellowships, investigator-initiated studies, patient registries, data collection, community outreach, and advocacy programs. The grants are awarded through an independent process, with Kyowa Kirin maintaining an arms-length relationship and not participating in project management.